Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Statement Issued by the Ministry of Public Health on the Measures Followed with Regard to the People Coming from China

 
The Ministry of Public Health issued the following statement on the measures taken with the travelers coming from China:

Upon recommendation of the World health Organization, the Ministry of Public Health is implementing the following measures with the travelers coming from China through the airport:
  1. Thermal screening through devices put in place at the airport to this end.
  2. When the traveler is exposing fever, he is transferred to the quarantine office where test is carried out on him.
  3. An information form is filled by travelers coming from all the Chinese regions who are on board, so as to follow up on them over the phone for two weeks (the incubation period of the virus) to make sure they do not show any symptoms.
  4. The form should be submitted to the plane crew before taking off. In case the form remained with the traveler for any reason whatsoever, it should be handed out to the quarantine office of the Ministry of Public Health at the airport when leaving the plane.
  5. In the event that a traveler coming China shows any symptoms within 14 days, he will be transferred to Rafik Hariri University Hospital for assessment and quarantined there if need be.
  6. The persons coming from the places where the coronavirus originated (Wuhan and some surrounding areas) will be quarantined at Rafik Hariri University Hospital (like what happened with one traveler so far).
  7. The persons coming from all the other areas in China are required to self-quarantined, and avoid contact with people for 14 days as of the day they leave China. They are also advised to call the Ministry of Public Health for any inquiry.
  8. The lab test for coronavirus, which is now available free of charge at Rafik Hariri University Hospital is conducted according to scientific and medical data determined by the Ministry of Public Health.
  9. The measures taken by the Ministry of Public Health are applied according to the recommendation of the World health Organization.
  10. The citizens are called on to collaborate in the implementation of the scientific and health measures required for the infection prevention.
  11. The Ministry of Public Health calls upon the citizens to act responsibly and not to spread rumors or baseless information.
    2
    ...
ATC Name B/G Ingredients Dosage Form Price
A11DB 3V G Vitamin B12 - 200mcg, Vitamin B6 - 200mg, Vitamin B1 - 100mg Tablet 229,797 L.L
A11DB 3V G Vitamin B12 - 1mg/3ml, Vitamin B6 - 100mg/3ml, Vitamin B1 - 100mg/3ml Injectable solution 198,889 L.L
B05BB02 5% DEXTROSE 0.45% SODIUM CHLORIDE INJECTION G Dextrose,H2O - 5g/100ml, Sodium chloride - 0.45g/100ml Injectable solution 179,272 L.L
B05BB02 5% DEXTROSE 0.45% SODIUM CHLORIDE INJECTION G Dextrose,H2O - 5g/100ml, Sodium chloride - 0.45g/100ml Injectable solution 224,090 L.L
B05BB02 5% DEXTROSE 0.45% SODIUM CHLORIDE INJECTION G Dextrose,H2O - 5g/100ml, Sodium chloride - 0.45g/100ml Injectable solution 153,990 L.L
B05BB02 5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION G Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml Injectable solution 180,421 L.L
B05BB02 5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION G Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml Injectable solution 226,388 L.L
B05BB02 5% DEXTROSE 0.9% SODIUM CHLORIDE INJECTION G Dextrose,H2O - 5g/100ml, Sodium chloride - 0.9g/100ml Injectable solution 153,990 L.L
B05CX01 5% DEXTROSE INJECTION USP G Glucose - 5% 5% Injectable solution 148,244 L.L
B05CX01 5% DEXTROSE INJECTION USP G Glucose - 5% 5% Injectable solution 148,244 L.L
B05CX01 5% DEXTROSE INJECTION USP G Glucose - 5% 5% Injectable solution 159,736 L.L
B05CX01 5% DEXTROSE INJECTION USP G Glucose - 5% 5% Injectable solution 179,272 L.L
B05CX01 5% DEXTROSE INJECTION USP G Glucose - 5% 5% Injectable solution 191,913 L.L
B05CX01 5% DEXTROSE INJECTION USP G Glucose - 5% 5% Injectable solution 191,913 L.L
B05CX01 5% DEXTROSE INJECTION USP G Glucose - 5% 5% Injectable solution 208,002 L.L
B05CX01 5% DEXTROSE INJECTION USP G Glucose - 5% 5% Injectable solution 224,090 L.L
B05CX01 5% DEXTROSE INJECTION USP G Glucose - 5% 5% Injectable solution 148,244 L.L
L01BC02 5-FLUOROURACIL EBEWE G Fluorouracil - 1000mg/20ml 1000mg/20ml Injectable concentrated solution 653,107 L.L
L01BC02 5-FROTU G Fluorouracil - 1000mg/20ml 1000mg/20ml Injectable solution 577,852 L.L
L01BC02 5-FROTU G Fluorouracil - 1000mg/20ml 1000mg/20ml Injectable solution L.L
B05CX01 7.5% DEXTROSE INJECTION USP G Dextrose monohydrate - 7.5% 7.5g/100ml Injectable solution 202,256 L.L
B05XA03 9% SODIUM CHLORIDE G Sodium chloride - 9g/100ml 0.9% Injectable solution 255,118 L.L
D10BA01 A-CNOTREN G Isotretinoin - 20mg 20mg Capsule, soft gelatin 1,526,524 L.L
D10AD01 A-RET G Tretinoin - 0.05% 0.05% Cream 335,961 L.L
N02BE51 A.B.C NIGHT G Paracetamol - 500mg, Diphenhydramine HCl - 25mg Tablet, film coated 222,694 L.L
N02BE51 A.B.C.-COLD G Paracetamol - 500mg, Chlorphenamine maleate - 4mg, Phenylephrine HCl - 5mg Tablet, film coated 534,977 L.L
B01AC06 A.S HEART G Acetylsalicylic acid - 81mg 81mg Tablet, enteric coated 148,463 L.L
N05AX12 ABILIFY MAINTENA B Aripiprazole - 400mg 400mg Injectable powder for suspension, prolonged release+solvent 29,491,998 L.L
N05AX12 ABIPREX 10 G Aripiprazole - 10mg 10mg Tablet 1,075,074 L.L
N05AX12 ABIPREX 15 G Aripiprazole - 15mg 15mg Tablet 1,075,074 L.L
    2
    ...
Sitemap
© Copyrights reserved to Ministry of Public Health 2026